BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17098001)

  • 1. Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen.
    Agüero J; Almenar L; Martinez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Izquierdo M; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2558-9. PubMed ID: 17098001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunosuppression regimen on heart transplantation survival.
    Agüero J; Almenar L; Martínez-Dolz L; Chamorro C; Moro J; Rueda J; Arnau MA; Zorio E; Izquierdo M; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2550-2. PubMed ID: 17097998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
    De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
    Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with single-dose daclizumab in the prevention of acute rejection in heart transplantation.
    Cuppoletti A; Perez-Villa F; Vallejos I; Roig E
    Transplant Proc; 2005 Nov; 37(9):4036-8. PubMed ID: 16386620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation.
    Aguero J; Almenar L; Martínez-Dolz L; Moro JA; Rueda J; Raso R; Chamorro C; Sanchez JM; Salvador A
    Clin Transplant; 2008; 22(1):98-106. PubMed ID: 18217910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutional changes in maintenance immunosuppression following heart transplantation.
    Sánchez-Lázaro I; Almenar L; Martínez-Dolz L; Chamorro C; Moro J; Agüero J; Rueda J; Zorio E; Arnau MA; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2553-4. PubMed ID: 17097999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.
    Miller LW; Naftel DC; Bourge RC; Kirklin JK; Brozena SC; Jarcho J; Hobbs RE; Mills RM
    J Heart Lung Transplant; 1994; 13(3):381-92; discussion 393. PubMed ID: 8061013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
    Crespo-Leiro MG; Alonso-Pulpón L; Arizón JM; Almenar L; Delgado JF; Palomo J; Manito N; Rábago G; Lage E; Diaz B; Roig E; Pascual D; Blasco T; de la Fuente L; Campreciós M; Vázquez de Prada JA; Muñiz J
    J Heart Lung Transplant; 2007 Nov; 26(11):1105-9. PubMed ID: 18022075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individual immunosuppressive regime in heart transplantation with high risk].
    Wu XJ; Chen LW; Chen DZ; Huang XS; Cao H
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):820-2. PubMed ID: 19035214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
    Birkeland SA; Hamilton-Dutoit S
    Transplantation; 2003 Sep; 76(6):984-8. PubMed ID: 14508366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-kidney transplant surgical complications under new immunosuppressive regimens.
    Burgos FJ; Pascual J; Quicios C; Marcen R; Fernández A; López Fando L; Ortuño J
    Transplant Proc; 2006 Oct; 38(8):2445-7. PubMed ID: 17097962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
    Marcén R; Morales JM; del Castillo D; Campistol JM; Serón D; Valdés F; Anaya F; Andrés A; Arias M; Bustamante J; Capdevila L; Escuin F; Gil-Vernet S; Gonzalez-Molina M; Lampreave I; Oppenheimer F; Pallardó L;
    Transplant Proc; 2006 Dec; 38(10):3530-2. PubMed ID: 17175323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen.
    Asano M; Gundry SR; Izutani H; Cannarella SN; Fagoaga O; Bailey LL
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):60-69; discussion 69-70. PubMed ID: 12538986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction therapy with daclizumab in heart transplantation--how many doses?
    Ortiz V; Almenar L; Martínez-Dolz L; Zorio E; Chamorro C; Moro J; Agüero J; Rueda J; Arnau MA; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2541-3. PubMed ID: 17097995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.
    Martins L; Fonseca I; Sousa S; Matos C; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2007 Oct; 39(8):2489-93. PubMed ID: 17954156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone fractures after cardiac transplantation.
    Luaces M; Crespo Leiro MG; Paniagua Martin MJ; de Lara JG; Rivas RM; Piñon Esteban P; Cursak G; Ríos R; Leira CN; Alonso JJ; Beiras AC
    Transplant Proc; 2007 Sep; 39(7):2393-6. PubMed ID: 17889200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.